SimulTOF Systems produces state of the art MALDI-TOF and TOF-TOF mass spectrometry solutions for biological and clinical research applications. Our Founder and Chief Scientific Officer, Dr. Marvin Vestal, received the 2010 award for a “Distinguished Contribution to Mass Spectrometry” from the American Society for Mass Spectrometry (ASMS). He is widely recognized for driving the commercialization of "delayed extraction" MALDI-TOF, which revolutionized the technology. The team at SimulTOF Systems has worked for several years on further advancements in time-of-flight mass spectrometry that we are now bringing to the market. Our hardware incorporates patented advances that represent a quantum leap in speed, sensitivity and selectivity in MALDI-TOF and TOF-TOF mass spectrometry. These unparalleled performance features are coupled with intuitive software to fully optimize the entire workflow; particularly for biomarker, proteomic and clinical research applications.

Financial Conflict of Interest Policy